Insider · CIK 0001273351

CARR EDWARD

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001273351

Forms 4 and 5

Insider transactions

45 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-17	DNTHDianthus Therapeutics, Inc. /DE/M Exercise/Conversion	CHIEF ACCOUNTING OFFICER	MExercise/Conversion	+20K sh	$17.88	+$358K	20,000
2026-09-17	DNTHDianthus Therapeutics, Inc. /DE/S Sale	CHIEF ACCOUNTING OFFICER	SSale	−7,928 sh	$100.43	−$796K	12,072
2026-09-17	DNTHDianthus Therapeutics, Inc. /DE/S Sale	CHIEF ACCOUNTING OFFICER	SSale	−6,771 sh	$101.37	−$686K	5,301
2026-09-17	DNTHDianthus Therapeutics, Inc. /DE/S Sale	CHIEF ACCOUNTING OFFICER	SSale	−3,501 sh	$102.39	−$358K	1,800
2026-09-17	DNTHDianthus Therapeutics, Inc. /DE/S Sale	CHIEF ACCOUNTING OFFICER	SSale	−1,100 sh	$103.20	−$114K	700
2026-09-17	DNTHDianthus Therapeutics, Inc. /DE/S Sale	CHIEF ACCOUNTING OFFICER	SSale	−700 sh	$104.39	−$73.1K	0
2026-09-17	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF ACCOUNTING OFFICER	MExercise/Conversion	−20K sh	—	—	43,818
2026-03-12	DNTHDianthus Therapeutics, Inc. /DE/M Exercise/Conversion	CHIEF ACCOUNTING OFFICER	MExercise/Conversion	+16.2K sh	$17.88	+$289K	16,182
2026-03-12	DNTHDianthus Therapeutics, Inc. /DE/M Exercise/Conversion	CHIEF ACCOUNTING OFFICER	MExercise/Conversion	+17.5K sh	$22.07	+$386K	33,682
2026-03-12	DNTHDianthus Therapeutics, Inc. /DE/M Exercise/Conversion	CHIEF ACCOUNTING OFFICER	MExercise/Conversion	+10K sh	$21.77	+$218K	43,682
2026-03-12	DNTHDianthus Therapeutics, Inc. /DE/S Sale	CHIEF ACCOUNTING OFFICER	SSale	−15.9K sh	$80.71	−$1.28M	27,830
2026-03-12	DNTHDianthus Therapeutics, Inc. /DE/S Sale	CHIEF ACCOUNTING OFFICER	SSale	−23.5K sh	$81.75	−$1.92M	4,365
2026-03-12	DNTHDianthus Therapeutics, Inc. /DE/S Sale	CHIEF ACCOUNTING OFFICER	SSale	−3,865 sh	$82.66	−$319K	500
2026-03-12	DNTHDianthus Therapeutics, Inc. /DE/S Sale	CHIEF ACCOUNTING OFFICER	SSale	−200 sh	$83.38	−$16.7K	300
2026-03-12	DNTHDianthus Therapeutics, Inc. /DE/S Sale	CHIEF ACCOUNTING OFFICER	SSale	−300 sh	$85.53	−$25.7K	0
2026-03-12	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF ACCOUNTING OFFICER	MExercise/Conversion	−16.2K sh	—	—	63,818
2026-03-12	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF ACCOUNTING OFFICER	MExercise/Conversion	−17.5K sh	—	—	42,500
2026-03-12	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF ACCOUNTING OFFICER	MExercise/Conversion	−10K sh	—	—	50,000
2026-02-03	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	CHIEF ACCOUNTING OFFICER	AAward	+55K sh	—	—	55,000
2025-02-03	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	CHIEF ACCOUNTING OFFICER	AAward	+60K sh	—	—	60,000
2024-05-23	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	CHIEF ACCOUNTING OFFICER	AAward	+60K sh	—	—	60,000
2024-01-24	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	CHIEF ACCOUNTING OFFICER	AAward	+80K sh	—	—	80,000
2021-10-08	ABEOABEONA THERAPEUTICS INC.S Sale	Chief Financial Officer	SSale	−29.1K sh	$1.05	−$30.6K	400,169
2021-08-10	ABEOABEONA THERAPEUTICS INC.A Award	Chief Financial Officer	AAward	+238K sh	—	—	429,291
2021-08-10	ABEOABEONA THERAPEUTICS INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+476K sh	—	—	476,000
2021-04-05	ABEOABEONA THERAPEUTICS INC.S Sale	Chief Financial Officer	SSale	−35K sh	$1.80	−$62.8K	191,291
2021-04-01	ABEOABEONA THERAPEUTICS INC.S Sale	Chief Financial Officer	SSale	−20.4K sh	$1.85	−$37.9K	226,291
2021-03-01	ABEOABEONA THERAPEUTICS INC.A Award	Chief Financial Officer	AAward	+50K sh	—	—	246,736
2021-03-01	ABEOABEONA THERAPEUTICS INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2020-11-20	ABEOABEONA THERAPEUTICS INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+28.9K sh	—	—	28,919
2020-11-20	ABEOABEONA THERAPEUTICS INC. · Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−28.9K sh	—	—	0
2020-11-20	ABEOABEONA THERAPEUTICS INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+51.1K sh	—	—	51,081
2020-11-20	ABEOABEONA THERAPEUTICS INC. · Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−51.1K sh	—	—	0
2020-11-20	ABEOABEONA THERAPEUTICS INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+10K sh	—	—	10,000
2020-11-20	ABEOABEONA THERAPEUTICS INC. · Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−10K sh	—	—	0
2020-11-20	ABEOABEONA THERAPEUTICS INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+35K sh	—	—	35,000
2020-11-20	ABEOABEONA THERAPEUTICS INC. · Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−35K sh	—	—	0
2020-10-09	ABEOABEONA THERAPEUTICS INC.A Award	Chief Financial Officer	AAward	+143K sh	—	—	196,736
2020-05-20	ABEOABEONA THERAPEUTICS INC.A Award	Chief Financial Officer	AAward	+40K sh	—	—	53,554
2020-05-20	ABEOABEONA THERAPEUTICS INC. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+28.9K sh	—	—	28,919
2020-03-19	ABEOABEONA THERAPEUTICS INC.S Sale	Chief Financial Officer	SSale	−6,446 sh	$1.81	−$11.7K	13,554
2020-03-16	ABEOABEONA THERAPEUTICS INC. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+51.1K sh	—	—	51,081
2019-09-12	ABEOABEONA THERAPEUTICS INC.A Award	Chief Financial Officer	AAward	+20K sh	—	—	20,000
2019-04-09	ABEOABEONA THERAPEUTICS INC. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+10K sh	—	—	10,000
2018-11-19	ABEOABEONA THERAPEUTICS INC. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+35K sh	—	—	35,000

Recent filings

Accepted (ET)
Sep 184
CARR EDWARD0001273351-26-000006
SEC(opens sec.gov)
Mar 134
CARR EDWARD0001273351-26-000004
SEC(opens sec.gov)
Feb 44
CARR EDWARD0001273351-26-000002
SEC(opens sec.gov)
Feb 44
CARR EDWARD0000950170-25-013516
SEC(opens sec.gov)

Companies

Address

C/O DIANTHUS THERAPEUTICS, INC. 7 TIMES SQUARE, 43RD FLOOR

NEW YORK, NY, 10036